ONCOtherapeutics Competitors and Similar CompaniesClear all
CEL-SCI's competitors and similar companies include Abliva and Topas Therapeutics.
 CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. |  Topas Therapeutics Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. | |
Founding Date | Founding Date 1983 | Founding Date 2000 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Vienna, US HQ | Locations Lund, SE HQ | Locations Hamburg, DE HQ Bremen, DE |
Employees | Employees N/A | Employees 950% increase | Employees N/A |
Financial | |||
Net income | Net income ($25.4m) (FY, 2025) | Net income (kr90m) (FY, 2024) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 10.8m | Total funding raised $ 20.8m |
For sources of this data, please see the company profile
View Company Profiles
Abliva
HQ
Lund, SE
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View companyTopas Therapeutics
HQ
Hamburg, DE
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.
View company